Valuation Amgen Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-08-14 EDT			5-day change	1st Jan Change
415.21 ^USD	-0.63%		+1.04%	+26.86%

08-14	Amgen Insider Sold Shares Worth $1,346,499, According to a Recent SEC Filing	MT
08-13	Daiwa Securities Adjusts Price Target on Amgen to $430 From $390, Keeps Outperform Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	126,718	140,139	154,142	140,103	176,250	224,476	-	-
Change	-	10.59%	9.99%	-9.11%	25.8%	27.36%	-	-
Enterprise Value (EV) ¹	151,990	169,779	207,811	188,229	221,725	266,144	260,489	255,433
Change	-	11.7%	22.4%	-9.42%	17.8%	20.03%	-2.12%	-1.94%
P/E	21.9x	21.7x	23.1x	34.5x	23x	26.3x	23.5x	22.7x
PBR	18.7x	38.3x	24.7x	23.8x	20.4x	20.3x	16.4x	13.2x
PEG	-	1.2x	7.36x	-0.9x	0.3x	2.4x	2x	6.13x
Capitalization / Revenue	4.88x	5.32x	5.47x	4.19x	4.8x	5.77x	5.61x	5.44x
EV / Revenue	5.85x	6.45x	7.37x	5.63x	6.03x	6.84x	6.51x	6.19x
EV / EBITDA	9.61x	10.5x	11.9x	9.13x	10.4x	12.1x	11.7x	11.5x
EV / EBIT	12.2x	13.3x	15.5x	12.5x	13.7x	15.7x	14.8x	14.1x
EV / FCF	18.1x	19.3x	28.2x	18.1x	27.4x	22.9x	18x	16.9x
FCF Yield	5.51%	5.17%	3.54%	5.52%	3.65%	4.36%	5.56%	5.91%
Dividend per Share ²	7.04	7.76	8.52	9	9.52	10.09	10.66	11.12
Rate of return	3.13%	2.95%	2.96%	3.45%	2.91%	2.43%	2.57%	2.68%
EPS ²	10.28	12.11	12.49	7.56	14.23	15.81	17.68	18.33
Distribution rate	68.5%	64.1%	68.2%	119%	66.9%	63.8%	60.3%	60.7%
Net sales ¹	25,979	26,323	28,190	33,424	36,751	38,890	40,003	41,242
EBITDA ¹	15,822	16,178	17,470	20,620	21,370	21,919	22,189	22,265
EBIT ¹	12,424	12,761	13,399	15,028	16,203	16,942	17,560	18,172
Net income ¹	5,893	6,552	6,717	4,090	7,711	8,598	9,394	9,890
Net Debt ¹	25,272	29,640	53,669	48,126	45,475	41,669	36,013	30,957
Reference price ²	224.97	262.64	288.02	260.64	327.31	415.21	415.21	415.21
Nbr of stocks (in thousands)	563,266	533,579	535,178	537,533	538,481	540,632	-	-
Announcement Date	2/7/22	1/31/23	2/6/24	2/4/25	2/3/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
AMGEN INC.	26.26x	6.84x	12.14x	2.43%	224B
ELI LILLY AND COMPANY	33.76x	12.18x	24.85x	0.59%	1,052B
JOHNSON & JOHNSON	28.96x	-	-	2.06%	627B
ABBVIE INC.	31.84x	7.42x	15.42x	2.75%	441B
ROCHE HOLDING AG	19.79x	4.7x	11.65x	2.81%	349B
NOVARTIS AG	21.42x	5.54x	13.77x	2.89%	287B
ASTRAZENECA PLC	19.89x	4.11x	11.68x	2.14%	241B
NOVO NORDISK A/S	13.32x	4.79x	9.96x	3.83%	202B
GILEAD SCIENCES, INC.	-42.28x	6.13x	23.96x	2.38%	172B
PFIZER INC.	16.79x	3.22x	8.21x	6.43%	153B
Average	16.97x	6.10x	14.63x	2.83%	374.79B
Weighted average by Cap.	23.87x	7.80x	17.26x	2.18%